253 related articles for article (PubMed ID: 36432107)
1. Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents.
Nurhidayah W; Setyawati LU; Daruwati I; Gazzali AM; Subroto T; Muchtaridi M
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432107
[TBL] [Abstract][Full Text] [Related]
2. Copper radiopharmaceuticals for theranostic applications.
Ahmedova A; Todorov B; Burdzhiev N; Goze C
Eur J Med Chem; 2018 Sep; 157():1406-1425. PubMed ID: 30282317
[TBL] [Abstract][Full Text] [Related]
3. The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker.
Holik HA; Ibrahim FM; Elaine AA; Putra BD; Achmad A; Kartamihardja AHS
Molecules; 2022 May; 27(10):. PubMed ID: 35630536
[TBL] [Abstract][Full Text] [Related]
4. Neopentyl Glycol as a Scaffold to Provide Radiohalogenated Theranostic Pairs of High
Suzuki H; Kaizuka Y; Tatsuta M; Tanaka H; Washiya N; Shirakami Y; Ooe K; Toyoshima A; Watabe T; Teramoto T; Sasaki I; Watanabe S; Ishioka NS; Hatazawa J; Uehara T; Arano Y
J Med Chem; 2021 Nov; 64(21):15846-15857. PubMed ID: 34708646
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Tumor Theranostics: An Update and Emerging Applications in Clinical Practice.
Sheikhbahaei S; Sadaghiani MS; Rowe SP; Solnes LB
AJR Am J Roentgenol; 2021 Aug; 217(2):495-506. PubMed ID: 34076455
[No Abstract] [Full Text] [Related]
6. Radionuclide Therapies in Molecular Imaging and Precision Medicine.
Kendi AT; Moncayo VM; Nye JA; Galt JR; Halkar R; Schuster DM
PET Clin; 2017 Jan; 12(1):93-103. PubMed ID: 27863570
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of 131I and 177Lu labeled somatostatin analogues for therapy of neuroendocrine tumours.
de Araújo EB; Caldeira Filho JS; Nagamati LT; Muramoto E; Colturato MT; Couto RM; Pujatti PB; Mengatti J; Silva CP
Appl Radiat Isot; 2009 Feb; 67(2):227-33. PubMed ID: 19027307
[TBL] [Abstract][Full Text] [Related]
8. Theranostic approaches in nuclear medicine: current status and future prospects.
Filippi L; Chiaravalloti A; Schillaci O; Cianni R; Bagni O
Expert Rev Med Devices; 2020 Apr; 17(4):331-343. PubMed ID: 32157920
[No Abstract] [Full Text] [Related]
9. Evaluation of Radioiodinated Fluoronicotinamide/Fluoropicolinamide-Benzamide Derivatives as Theranostic Agents for Melanoma.
Chen CC; Chen YY; Lo YH; Lin MH; Chang CH; Chen CL; Wang HE; Wu CY
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916962
[TBL] [Abstract][Full Text] [Related]
10. "Naked" radiopharmaceuticals.
Wallner PE
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S60-1. PubMed ID: 16979442
[TBL] [Abstract][Full Text] [Related]
11. Iodination and radiolabeling of alpha-allocryptopine with iodine-125.
Wei Y; Wei X; Wang Y; Liu X; Chu T; Hu S; Wang X
Appl Radiat Isot; 2005 Jan; 62(1):55-62. PubMed ID: 15498685
[TBL] [Abstract][Full Text] [Related]
12. The next generation of positron emission tomography radiopharmaceuticals in oncology.
Rice SL; Roney CA; Daumar P; Lewis JS
Semin Nucl Med; 2011 Jul; 41(4):265-82. PubMed ID: 21624561
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts.
Kievit E; van Gog FB; Schlüper HM; van Dongen GA; Pinedo HM; Boven E
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):813-23. PubMed ID: 9240651
[TBL] [Abstract][Full Text] [Related]
14. Updated Review of Nuclear Molecular Imaging of Thyroid Cancers.
Fu H; Sa R; Cheng L; Jin Y; Qiu X; Liu M; Chen L
Endocr Pract; 2021 May; 27(5):494-502. PubMed ID: 33934754
[TBL] [Abstract][Full Text] [Related]
15. Ionic liquid supported organotin reagents to prepare molecular imaging and therapy agents.
Rajerison H; Faye D; Roumesy A; Louaisil N; Boeda F; Faivre-Chauvet A; Gestin JF; Legoupy S
Org Biomol Chem; 2016 Feb; 14(6):2121-6. PubMed ID: 26782686
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical and clinical development of phosphonate-based radiopharmaceuticals for the targeted treatment of bone metastases.
Lange R; Ter Heine R; Knapp RF; de Klerk JM; Bloemendal HJ; Hendrikse NH
Bone; 2016 Oct; 91():159-79. PubMed ID: 27496068
[TBL] [Abstract][Full Text] [Related]
17. Radioiodinated tracers for myocardial imaging.
Kulkarni PV; Corbett JR
Semin Nucl Med; 1990 Apr; 20(2):119-29. PubMed ID: 2184520
[TBL] [Abstract][Full Text] [Related]
18. Iodine-124: a promising positron emitter for organic PET chemistry.
Koehler L; Gagnon K; McQuarrie S; Wuest F
Molecules; 2010 Apr; 15(4):2686-718. PubMed ID: 20428073
[TBL] [Abstract][Full Text] [Related]
19. [131I]MIBG radionuclide therapy in carcinoid syndrome.
Taal BG; Zuetenhorst H; Valdés Olmos RA; Hoefnagel CA
Eur J Surg Oncol; 2002 Apr; 28(3):243. PubMed ID: 11944956
[No Abstract] [Full Text] [Related]
20. Radiochemical and radiobiological alterations of I 131-labeled proteins in solution.
BERSON SA; YALOW RS
Ann N Y Acad Sci; 1957 Aug; 70(1):56-68. PubMed ID: 13488254
[No Abstract] [Full Text] [Related]
[Next] [New Search]
